Washington, DC · Mass tort & product liability, nationwide Free case review: (888) 391‑1315

Hair relaxer litigation

Lawsuits allege that chemical hair relaxers, marketed for decades primarily to Black women, contain endocrine-disrupting chemicals linked to uterine and ovarian cancer.

Accepting cases
An unlabeled cosmetic jar with its lid ajar on dark marble

What the lawsuits allege

A 2022 National Institutes of Health study found that women who used chemical straighteners more than four times a year had a significantly higher rate of uterine cancer. The litigation alleges manufacturers formulated relaxers with phthalates and other endocrine disruptors and marketed them aggressively without warning of those risks. Thousands of cases are coordinated in a federal multidistrict litigation in Illinois.

Injuries named in the litigation

  • Uterine (endometrial) cancer
  • Ovarian cancer
  • Uterine fibroids requiring hysterectomy alleged in filings

Who may qualify

If you used chemical hair relaxers regularly and were diagnosed with uterine cancer, ovarian cancer, or required a hysterectomy for qualifying conditions, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.

Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.